Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma (MREO) Interest & Investment Income (2023 - 2025)

Historic Interest & Investment Income for Mereo BioPharma (MREO) over the last 3 years, with Q3 2025 value amounting to $504000.0.

  • Mereo BioPharma's Interest & Investment Income fell 4872.84% to $504000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 989.05%. This contributed to the annual value of $3.0 million for FY2024, which is 4270.3% up from last year.
  • Latest data reveals that Mereo BioPharma reported Interest & Investment Income of $504000.0 as of Q3 2025, which was down 4872.84% from $589000.0 recorded in Q2 2025.
  • In the past 5 years, Mereo BioPharma's Interest & Investment Income registered a high of $983000.0 during Q3 2024, and its lowest value of $306000.0 during Q1 2023.
  • Moreover, its 3-year median value for Interest & Investment Income was $617000.0 (2024), whereas its average is $629363.6.
  • In the last 5 years, Mereo BioPharma's Interest & Investment Income soared by 10163.4% in 2024 and then plummeted by 4872.84% in 2025.
  • Quarter analysis of 3 years shows Mereo BioPharma's Interest & Investment Income stood at $763000.0 in 2023, then increased by 15.47% to $881000.0 in 2024, then crashed by 42.79% to $504000.0 in 2025.
  • Its Interest & Investment Income stands at $504000.0 for Q3 2025, versus $589000.0 for Q2 2025 and $659000.0 for Q1 2025.